Different requirements for α‐galactosylceramide and recombinant IL‐12 antitumor activity in the treatment of C‐26 colon carcinoma hepatic metastases

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Immunology

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1521-4141(2001010)31:10<3101::AID-IMMU3101>3.0.CO;2-8PMID 11592087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental model for liver metastasis formation using lewis lung tumor

  2004cited by this paper
• Immune suppression and skin cancer development: regulation by NKT cells

  2000cited by this paper
• CD1d-restricted and TCR-mediated activation of V α14 NKT cells by glycosylceramides

  2000cited by this paper
• NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway

  2000cited by this paper
• Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12.

  2000cited by this paper
• Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

  2000cited by this paper
• Activation of hepatic NKT cells and subsequent liver injury following administration of α‐galactosylceramide

  2000cited by this paper
• NKT cells are phenotypically and functionally diverse

  1999cited by this paper
• Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.

  1999cited by this paper
• The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

  1999cited by this paper
• Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.

  1999cited by this paper
• Interferon (cid:103) –independent Rejection of Interleukin 12–transduced Carcinoma Cells Requires CD4 (cid:49) T Cells and Granulocyte/Macrophage Colony–stimulating Factor

  1998cited by this paper
• Critical role of NK1+ T cells in IL-12-induced immune responses in vivo.

  1998cited by this paper
• Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo

  1998cited by this paper
• Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.

  1998cited by this paper
• Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

  1998cited by this paper
• Mouse CD1-specific NK1 T cells: development, specificity, and function.

  1997cited by this paper
• Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

  1997cited by this paper
• Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

  1997cited by this paper
• Interleukin-12: role of interferon-gamma in IL-12 adverse effects.

  1997cited by this paper
• CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

  1997cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• Interleukin-12: Role of Interferon-γ in IL-12 Adverse Effects

  1997cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells.

  1996cited by this paper
• Antitumor activities of combined treatment with a novel immunomodulator, (2S,3S,4R)-1-O-(alpha-D-Galactopyranosyl)-2-(N-Hexacosanoylamino)-1,3,4 - octadecanetriol (KRN7000), and radiotherapy in tumor-bearing mice.

  1996cited by this paper
• KRN7000, a novel immunomodulator, and its antitumor activities.

  1995cited by this paper
• Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes.

  1995cited by this paper
• CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes

  1995cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper
• Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice

  1994cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Antitumor and antimetastatic activity of interleukin 12 against murine tumors

  1993cited by this paper
• Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

  1993cited by this paper
• Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma

  1993cited by this paper

• Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity

  2024cites this paper
• Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours

  2023cites this paper
• Cytokine conjugation to enhance T cell therapy

  2022cites this paper
• Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control

  2020cites this paper
• Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward

  2020cites this paper
• Glycolipid Stimulation of Invariant NKT Cells Expands a Unique Tissue-Resident Population of Precursors to Mature NK Cells Endowed with Oncolytic and Antimetastatic Properties

  2019cites this paper
• High Aspect Ratio Viral Nanoparticles for Cancer Therapy

  2016cites this paper
• Host CD40 Is Essential for DCG Treatment Against Metastatic Lung Cancer.

  2016cites this paper
• Liver Injury After Invariant NKT Cell Activation by Free Alpha-galactosylceramide and Alpha-galactosylceramide-loaded Dendritic Cells.

  2016cites this paper
• Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation.

  2014cites this paper
• The impact of surgical extent and sex on the hepatic metastasis of colon cancer

  2014cites this paper
• Anti-nociceptive effect of IL-12p40 in a rat model of neuropathic pain.

  2013cites this paper
• Dissecting the Roles of Natural Killer T cells in Autoimmune Disorders and Malignancy

  2013cites this paper
• The Role of NKT Cells in the Immune Regulation of Neoplastic Disease

  2012cites this paper
• Immune Regulation of Tumor Immunity by NKT Cells

  2012cites this paper
• Cancer Therapy : Clinical A Phase 1 Study of AS 1409 , a Novel Antibody-Cytokine Fusion Protein , in Patients with Malignant Melanoma or Renal Cell Carcinoma

  2011cites this paper
• IL-12 initiates tumor rejection via LTi cells bearing the natural cytotoxicity receptor NKp46

  2011cites this paper
• A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma

  2011cites this paper
• Regulation of tumor immunity: the role of NKT cells

  2008influential citation
• TLR-independent induction of human monocyte IL-1 by phosphoglycolipids from thermophilic bacteria

  2008cites this paper
• Development of Immunotherapy Against Prostate Cancer Using Lentivirally-transduced Dendritic Cells Expressing Murine erbB2 as a Model Tumor-associated Antigen

  2008cites this paper
• Surgery as a Risk Factor for Breast Cancer Recurrence and Metastasis: Mediating Mechanisms and Clinical Prophylactic Approaches

  2007cites this paper
• Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor.

  2007cites this paper
• Experimental Models of Cytokines and Cancer Prevention

  2007cites this paper
• Intrahepatic delivery of α‐galactosylceramide‐pulsed dendritic cells suppresses liver tumor

  2007cites this paper
• Dual function for the adaptor MIST in IFN-gamma production by NK and CD4+NKT cells regulated by the Src kinase Fgr.

  2006cites this paper
• Dual function for the adaptor MIST in IFN- (cid:1) production by NK and CD4 (cid:2) NKT cells regulated by the Src kinase Fgr

  2006cites this paper
• Attenuate Graft-versus-Host Immunity Host-Residual Invariant NK T Cells

  2005cites this paper
• Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity1

  2005cites this paper
• Role of natural killer cells in antitumor resistance

  2005cites this paper
• Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients

  2004cites this paper
• Experimental colon cancer

  2003cites this paper
• Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.

  2003cites this paper
• Interleukin-12 in anti-tumor immunity and immunotherapy.

  2002cites this paper
• Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.

  2002cites this paper